期刊文献+

非小细胞肺癌的遗传易感性与转化生长因子-β受体Ⅰ基因的关系

Relationship between genetic susceptibility of non-small cell lung cancer and the TGF-βRI gene
原文传递
导出
摘要 目的探讨转化生长因子-β受体Ⅰ(TGF-βRI)基因与非小细胞肺癌(NSCLC)遗传易感性的关系。方法采用单链构象多态性分析(SSCP)和DNA测序方法,观察53例原发性NSCLC组织的TGF—βRI基因的整个密码区域以及旁侧内含子序列的改变。结果未见任何体细胞水平的突变,但在TGF—βRI基因中发现了两个沉默突变和一个多态性位点。两个沉默突变分别位于密码子的344位(由ATT突变成AAC)和密码子的406位(由TTA突变成CTA)。多态性位点位于该基因的第7号内含子中的第24位核苷酸处(由G突变成A)。根据病例组和对照组分析,可见纯合基因型A/A携带者患非小细胞肺癌的风险比野生基因型G/G的携带者高出3倍以上。结论TGF-βRI基因虽然不是自发突变失活的频繁位点,但是此处研究的多态性可能具有NSCLC的遗传易感性。 Objective To-investigate whether the transforming growth factor-beta receptor type Ⅰ (TGF-βRI) gene is associated with genetic predisposition of primary non-small cell lung cancer (NSCLC). Methods The entire coding region of TGF-βRI and flanking intron sequences from 53 NSCLC tissues were examined for alterations using SSCP and direct sequencing. Results No somatic point muta- tions other than two silent mutations and a polymorphism were found in the TGF-βRI gene. The two silent mutations located at codon 544 (AAT to AAC) and codon 406 (TTA to CTA), respectively, and the polymorphism was at 24 th base of intron7 ( G to A). Interestingly, we found that the subjects with homozygous genotype A/A displayed more than threefold increased risk of developing NSCLC than the common wild genotype G/G. Conclusion As the first report,this study showed that TGF-βRI gene is not a frequent site of spontaneous mutational inactivation while the detected polymorphism could be a susceptibility allele that predisposes to carcinogenesis of NSCLC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第11期1466-1468,共3页 Chinese Journal of Experimental Surgery
基金 辽宁省科技攻关计划(JH2)资助项目(2005225003-15)
关键词 转化生长因子-β受体Ⅰ 非小细胞肺癌 多态性 突变 TGF-βRI NSCLC Mutation Polymorphism
  • 相关文献

参考文献12

  • 1Attisano L,Wrana JL. Signal transduction by the TGF-beta superfamily. Science ,2002,296 : 1646-1647.
  • 2Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogenactivated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene,2005,24:5742- 5750.
  • 3徐茜,刘福安,吴莺,赵赟,吴剑宏,龚建平,马丁.转化生长因子-β1对乳腺癌细胞株增殖和T淋巴细胞免疫的影响[J].中华实验外科杂志,2005,22(6):695-697. 被引量:5
  • 4周瑞,熊斌,王新波.可溶性转化生长因子βⅡ型受体对大肠癌生物学行为的影响[J].中华实验外科杂志,2007,24(12):1545-1547. 被引量:3
  • 5Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997,111 : 1710-1717.
  • 6Shubeita HE, Sambrook JF, McCormick AM. Molecular cloning and analysis of functional cDNA and genomic clones encoding bovine cellular retinoic acid-binding protein. Proc Natl Acad Sci USA, 1987,84: 5645 -5649.
  • 7Chen T, Carter D, Garrigue-Antar L, et al. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res, 1998,58:4805-4810.
  • 8Sunde JS, Donninger H, Wu K, et al. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res, 2006,66:8404-8412.
  • 9Deckers M, van Dinther M, Buijs J, et al. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res,2006,66:2202-2209.
  • 10Glasgow E, Mishra L. Transforming growth factor-beta signaling and ubiquitinators in cancer. Endocr Relat Cancer,2008,15:59-72.

二级参考文献13

  • 1王文清,邱双健,吴志全,樊嘉,叶胜龙,李新丰,叶超平.肝细胞癌根治性切除术后复发转移与血清转化生长因子-β1的关系[J].中华实验外科杂志,2005,22(1):100-101. 被引量:18
  • 2Kloos DU,Choi C,Wingender E.The TGF-beta-Smad network:introducing bioinformatic tools.Trends Genet,2002,18:96-103.
  • 3Chorna I,Bilyy R,Datsyuk L,et al.Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin:effect of ionizing radiation on apoptosis and TGF-beta production.Eksp Onkol,2004,26:111-117.
  • 4Tang B,Vu M,Booker T,et al.TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.J Clin Invest,2003,112:1116-1124.
  • 5Wakefield LM,Roberts AB.TGF-beta signaling:positive and negative effects on tumorigenesis.Curr Opin Genet Dev,2002,12:22-29.
  • 6Deguchi R,Takagi A,Kawata H,et al.Association between CagA+ Helicobacter pylori infection and p53,bax and transforming growth factor-beta-RⅡ gene mutations in gastric cancer patients.Int J Cancer,2001,91:481-485.
  • 7Calin GA,Gafa R,Tibiletti MG,et al.Genetic progression in microsatellite instability high colon cancers correlated wit clinico-pathological parameters:A study of the TGF-βRⅢ,BAX,HMSH3,HMSH6,IGFⅡR,and BLM gene.Int -235.J Cancer,2000,89:230.
  • 8Hazelbag S,Gorter A,Kenter GG,et al.Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.Hum Pathol,2002,33:1193-1199.
  • 9Yamada SD,Baldwin RL,Karlan BY.Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.Gynecol Oncol,1999,75:72-77.
  • 10Ten Dijke P,Goumans MJ,Itoh F,et al.Regulation of cell proliferation by Smad proteins.J Cell Physiol,2002,191:1-16.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部